DUODOPA

This brand name is authorized in Australia, Austria, Canada, Croatia, Cyprus, Estonia, Finland, France, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, South Africa, Spain, Turkey, UK.

Active ingredients

The drug DUODOPA contains a combination of these active pharmaceutical ingredients (APIs):

1	Levodopa UNII 46627O600J - LEVODOPA
	According to the current understanding, the symptoms of Parkinson’s disease are related to depletion of dopamine in the corpus striatum. Dopamine does not cross the blood-brain barrier. Levodopa, the precursor of dopamine, crosses the blood brain barrier and relieves the symptoms of the disease.
	Read more about Levodopa
2	Carbidopa UNII MNX7R8C5VO - CARBIDOPA
	Carbidopa is a peripheral aromatic amino acid decarboxylase inhibitor. It prevents metabolism of levodopa to dopamine in the peripheral circulation, ensuring that a higher proportion of the dose reaches the brain, where dopamine exerts its therapeutic effects. A lower dose of levodopa can be used when it is coadministered with carbidopa, reducing the incidence and severity of peripheral side effects.
	Read more about Carbidopa

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N04BA02	Levodopa and decarboxylase inhibitor	N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BA Dopa and dopa derivatives
Discover more medicines within N04BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11910W, 11913B, 11919H, 8970D, 9743T, 9744W
CA	Health Products and Food Branch	02292165
EE	Ravimiamet	1192867
ES	Centro de información online de medicamentos de la AEMPS	66547
FI	Lääkealan turvallisuus- ja kehittämiskeskus	095314
FR	Base de données publique des médicaments	64757532
GB	Medicines & Healthcare Products Regulatory Agency	101620
HR	Agencija za lijekove i medicinske proizvode	HR-H-753613005
IE	Health Products Regulatory Authority	89058
IL	מִשְׂרַד הַבְּרִיאוּת	6662
JP	医薬品医療機器総合機構	1169101S1020
LT	Valstybinė vaistų kontrolės tarnyba	1021102
NL	Z-Index G-Standaard, PRK	77569
NZ	Medicines and Medical Devices Safety Authority	16907
PL	Rejestru Produktów Leczniczych	100150430
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W60962001
TR	İlaç ve Tıbbi Cihaz Kurumu	8680656080063
ZA	Health Products Regulatory Authority	44/5.4.1/0456